Ann Partridge
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Ann Partridge
Jun 14, 2024, 13:52 |
Blog
Maria Vidal: Grateful to Ann Partridge and her team at DFCI for this amazing opportunity
Maria Vidal, Medical Oncologist at Hospital Clinic and IOB Institute of Oncology Barcelona, shared a…
May 24, 2024, 12:47 |
Positive
Ann Partridge was selected for a Research Professorship by the American Cancer Society - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "Congratulations to Ann Partridge MD who was selected for…
Dec 17, 2023, 17:21 |
Insight
SABCS23 Day 3 Highlights by Oncology Brothers
Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the third day's…
Dec 10, 2023, 16:53 |
Positive
Matteo Lambertini: December 7, 2023 …a day to remember
Matteo Lambertini, Associate Professor at the University of Genova, shared on LinkedIn: "December 7, 2023…
Nov 2, 2023, 01:30 |
Blog
Kimia Sorouri: We explore the conception and pregnancy outcomes of young breast cancer survivors to inform patient counseling
Kimia Sorouri, Research Fellow at Harvard Medical School and Dana-Farber Cancer Institute, made the following…
Oct 17, 2023, 01:39 |
Career
Nancy Lin: Congratulations to Ann Partridge as the inaugural recipient of the Eric P. Winer Chair in Breast Cancer Research
Nancy Lin, Breast cancer specialist at Dana-Farber Cancer Centre, shared on X/Twitter: "Congratulations to my…
Sep 12, 2023, 19:59 |
Blog
Join us in person for a meet the experts event at Dana-Farber in Boston on 9/22. - Dana-Farber
Dana-Farber shared in their X/Twitter post: ''Join us in person for a meet the experts…
Aug 27, 2023, 18:29 |
Blog
Narjust Florez: Join us as we discuss the role of cultural humility in cancer survivorship in this conversation with my mentor Dr. Ann Partridge.
Narjust Florez, the Associate Director of the Cancer Care Equity Program at the Dana-Farber Brigham…
All:
8
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube